ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global EGFR Mutation Test Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-20Z6130
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global EGFR Mutation Test Market Insights and Forecast to 2028
BUY CHAPTERS

Global EGFR Mutation Test Market Research Report 2025

Code: QYRE-Auto-20Z6130
Report
August 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott
Merck
Thermo Fisher Scientific
Illumina Inc
Biomerieux
Qiagen NV
Agilent Technologies
Hologic Inc
Novartis
Roche
Genomic Health

EGFR Mutation Test Market

The global market for EGFR Mutation Test was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Epidermal growth factor receptor (EGFR) is a type of protein, which is located on the surface of human body cells. Any mutation in EGFR gene can lead to various types of cancer. EGFR functions as a biomarker for non-small cell lung cancer (NSCLC) and due to the mutation of EGFR gene a person may suffer from cancer or may have a tumor growth. Tumors with genetically altered EGFR gene are referred to as EGFR-mutated tumors. EGFR mutation is generally observed in NSCLCs, especially in adenocarcinoma tumors. According to the International Association for the Study of Lung Cancer, American Thoracic Society and European Respiratory Society, there are around 50% of surgically resected lung adenocarcinomas in EGFR mutations. These mutations are related to micro papillary predominant subtype and the bronchioloalveolar carcinoma. EGFR biomarker is used in diagnosis of patients with NSCLC. Targeted therapy involving tyrosine kinase inhibitors such as gefitinib and erotinib is used in the treatment of patients with NSCLC. EGFR biomarker detects the presence of specific alterations in EGFR gene, which may lead to the development of tumor.
Increasing global prevalence of lung cancer is expected to fuel growth of the global EGFR mutation test market over the forecast period. Increasing adoption of biomarker therapy is also expected to boost growth of the market worldwide over the forecast period.
This report aims to provide a comprehensive presentation of the global market for EGFR Mutation Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding EGFR Mutation Test.
The EGFR Mutation Test market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global EGFR Mutation Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the EGFR Mutation Test companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of EGFR Mutation Test Market Report

Report Metric Details
Report Name EGFR Mutation Test Market
Segment by Type
  • DNA Sequencing
  • Kits
Segment by Application
  • Cancer Hospitals
  • Clinical Research Institutes
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott, Merck, Thermo Fisher Scientific, Illumina, BioMerieux, QIAGEN, Agilent Technologies, Hologic, Novartis, Roche, Genomic Health
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of EGFR Mutation Test company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the EGFR Mutation Test Market report?

Ans: The main players in the EGFR Mutation Test Market are Abbott, Merck, Thermo Fisher Scientific, Illumina, BioMerieux, QIAGEN, Agilent Technologies, Hologic, Novartis, Roche, Genomic Health

What are the Application segmentation covered in the EGFR Mutation Test Market report?

Ans: The Applications covered in the EGFR Mutation Test Market report are Cancer Hospitals, Clinical Research Institutes

What are the Type segmentation covered in the EGFR Mutation Test Market report?

Ans: The Types covered in the EGFR Mutation Test Market report are DNA Sequencing, Kits

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global EGFR Mutation Test Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 DNA Sequencing
1.2.3 Kits
1.3 Market by Application
1.3.1 Global EGFR Mutation Test Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer Hospitals
1.3.3 Clinical Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global EGFR Mutation Test Market Perspective (2020-2031)
2.2 Global EGFR Mutation Test Growth Trends by Region
2.2.1 Global EGFR Mutation Test Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 EGFR Mutation Test Historic Market Size by Region (2020-2025)
2.2.3 EGFR Mutation Test Forecasted Market Size by Region (2026-2031)
2.3 EGFR Mutation Test Market Dynamics
2.3.1 EGFR Mutation Test Industry Trends
2.3.2 EGFR Mutation Test Market Drivers
2.3.3 EGFR Mutation Test Market Challenges
2.3.4 EGFR Mutation Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top EGFR Mutation Test Players by Revenue
3.1.1 Global Top EGFR Mutation Test Players by Revenue (2020-2025)
3.1.2 Global EGFR Mutation Test Revenue Market Share by Players (2020-2025)
3.2 Global EGFR Mutation Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by EGFR Mutation Test Revenue
3.4 Global EGFR Mutation Test Market Concentration Ratio
3.4.1 Global EGFR Mutation Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by EGFR Mutation Test Revenue in 2024
3.5 Global Key Players of EGFR Mutation Test Head office and Area Served
3.6 Global Key Players of EGFR Mutation Test, Product and Application
3.7 Global Key Players of EGFR Mutation Test, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 EGFR Mutation Test Breakdown Data by Type
4.1 Global EGFR Mutation Test Historic Market Size by Type (2020-2025)
4.2 Global EGFR Mutation Test Forecasted Market Size by Type (2026-2031)
5 EGFR Mutation Test Breakdown Data by Application
5.1 Global EGFR Mutation Test Historic Market Size by Application (2020-2025)
5.2 Global EGFR Mutation Test Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America EGFR Mutation Test Market Size (2020-2031)
6.2 North America EGFR Mutation Test Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America EGFR Mutation Test Market Size by Country (2020-2025)
6.4 North America EGFR Mutation Test Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe EGFR Mutation Test Market Size (2020-2031)
7.2 Europe EGFR Mutation Test Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe EGFR Mutation Test Market Size by Country (2020-2025)
7.4 Europe EGFR Mutation Test Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific EGFR Mutation Test Market Size (2020-2031)
8.2 Asia-Pacific EGFR Mutation Test Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific EGFR Mutation Test Market Size by Region (2020-2025)
8.4 Asia-Pacific EGFR Mutation Test Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America EGFR Mutation Test Market Size (2020-2031)
9.2 Latin America EGFR Mutation Test Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America EGFR Mutation Test Market Size by Country (2020-2025)
9.4 Latin America EGFR Mutation Test Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa EGFR Mutation Test Market Size (2020-2031)
10.2 Middle East & Africa EGFR Mutation Test Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa EGFR Mutation Test Market Size by Country (2020-2025)
10.4 Middle East & Africa EGFR Mutation Test Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott EGFR Mutation Test Introduction
11.1.4 Abbott Revenue in EGFR Mutation Test Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck EGFR Mutation Test Introduction
11.2.4 Merck Revenue in EGFR Mutation Test Business (2020-2025)
11.2.5 Merck Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific EGFR Mutation Test Introduction
11.3.4 Thermo Fisher Scientific Revenue in EGFR Mutation Test Business (2020-2025)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Illumina
11.4.1 Illumina Company Details
11.4.2 Illumina Business Overview
11.4.3 Illumina EGFR Mutation Test Introduction
11.4.4 Illumina Revenue in EGFR Mutation Test Business (2020-2025)
11.4.5 Illumina Recent Development
11.5 BioMerieux
11.5.1 BioMerieux Company Details
11.5.2 BioMerieux Business Overview
11.5.3 BioMerieux EGFR Mutation Test Introduction
11.5.4 BioMerieux Revenue in EGFR Mutation Test Business (2020-2025)
11.5.5 BioMerieux Recent Development
11.6 QIAGEN
11.6.1 QIAGEN Company Details
11.6.2 QIAGEN Business Overview
11.6.3 QIAGEN EGFR Mutation Test Introduction
11.6.4 QIAGEN Revenue in EGFR Mutation Test Business (2020-2025)
11.6.5 QIAGEN Recent Development
11.7 Agilent Technologies
11.7.1 Agilent Technologies Company Details
11.7.2 Agilent Technologies Business Overview
11.7.3 Agilent Technologies EGFR Mutation Test Introduction
11.7.4 Agilent Technologies Revenue in EGFR Mutation Test Business (2020-2025)
11.7.5 Agilent Technologies Recent Development
11.8 Hologic
11.8.1 Hologic Company Details
11.8.2 Hologic Business Overview
11.8.3 Hologic EGFR Mutation Test Introduction
11.8.4 Hologic Revenue in EGFR Mutation Test Business (2020-2025)
11.8.5 Hologic Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis EGFR Mutation Test Introduction
11.9.4 Novartis Revenue in EGFR Mutation Test Business (2020-2025)
11.9.5 Novartis Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche EGFR Mutation Test Introduction
11.10.4 Roche Revenue in EGFR Mutation Test Business (2020-2025)
11.10.5 Roche Recent Development
11.11 Genomic Health
11.11.1 Genomic Health Company Details
11.11.2 Genomic Health Business Overview
11.11.3 Genomic Health EGFR Mutation Test Introduction
11.11.4 Genomic Health Revenue in EGFR Mutation Test Business (2020-2025)
11.11.5 Genomic Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Abbott
Merck
Thermo Fisher Scientific
Illumina Inc
Biomerieux
Qiagen NV
Agilent Technologies
Hologic Inc
Novartis
Roche
Genomic Health
List of Tables
 Table 1. Global EGFR Mutation Test Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of DNA Sequencing
 Table 3. Key Players of Kits
 Table 4. Global EGFR Mutation Test Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global EGFR Mutation Test Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global EGFR Mutation Test Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global EGFR Mutation Test Market Share by Region (2020-2025)
 Table 8. Global EGFR Mutation Test Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global EGFR Mutation Test Market Share by Region (2026-2031)
 Table 10. EGFR Mutation Test Market Trends
 Table 11. EGFR Mutation Test Market Drivers
 Table 12. EGFR Mutation Test Market Challenges
 Table 13. EGFR Mutation Test Market Restraints
 Table 14. Global EGFR Mutation Test Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global EGFR Mutation Test Market Share by Players (2020-2025)
 Table 16. Global Top EGFR Mutation Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in EGFR Mutation Test as of 2024)
 Table 17. Ranking of Global Top EGFR Mutation Test Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by EGFR Mutation Test Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of EGFR Mutation Test, Headquarters and Area Served
 Table 20. Global Key Players of EGFR Mutation Test, Product and Application
 Table 21. Global Key Players of EGFR Mutation Test, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global EGFR Mutation Test Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global EGFR Mutation Test Revenue Market Share by Type (2020-2025)
 Table 25. Global EGFR Mutation Test Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global EGFR Mutation Test Revenue Market Share by Type (2026-2031)
 Table 27. Global EGFR Mutation Test Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global EGFR Mutation Test Revenue Market Share by Application (2020-2025)
 Table 29. Global EGFR Mutation Test Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global EGFR Mutation Test Revenue Market Share by Application (2026-2031)
 Table 31. North America EGFR Mutation Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America EGFR Mutation Test Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America EGFR Mutation Test Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe EGFR Mutation Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe EGFR Mutation Test Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe EGFR Mutation Test Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific EGFR Mutation Test Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific EGFR Mutation Test Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific EGFR Mutation Test Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America EGFR Mutation Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America EGFR Mutation Test Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America EGFR Mutation Test Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa EGFR Mutation Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa EGFR Mutation Test Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa EGFR Mutation Test Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Abbott Company Details
 Table 47. Abbott Business Overview
 Table 48. Abbott EGFR Mutation Test Product
 Table 49. Abbott Revenue in EGFR Mutation Test Business (2020-2025) & (US$ Million)
 Table 50. Abbott Recent Development
 Table 51. Merck Company Details
 Table 52. Merck Business Overview
 Table 53. Merck EGFR Mutation Test Product
 Table 54. Merck Revenue in EGFR Mutation Test Business (2020-2025) & (US$ Million)
 Table 55. Merck Recent Development
 Table 56. Thermo Fisher Scientific Company Details
 Table 57. Thermo Fisher Scientific Business Overview
 Table 58. Thermo Fisher Scientific EGFR Mutation Test Product
 Table 59. Thermo Fisher Scientific Revenue in EGFR Mutation Test Business (2020-2025) & (US$ Million)
 Table 60. Thermo Fisher Scientific Recent Development
 Table 61. Illumina Company Details
 Table 62. Illumina Business Overview
 Table 63. Illumina EGFR Mutation Test Product
 Table 64. Illumina Revenue in EGFR Mutation Test Business (2020-2025) & (US$ Million)
 Table 65. Illumina Recent Development
 Table 66. BioMerieux Company Details
 Table 67. BioMerieux Business Overview
 Table 68. BioMerieux EGFR Mutation Test Product
 Table 69. BioMerieux Revenue in EGFR Mutation Test Business (2020-2025) & (US$ Million)
 Table 70. BioMerieux Recent Development
 Table 71. QIAGEN Company Details
 Table 72. QIAGEN Business Overview
 Table 73. QIAGEN EGFR Mutation Test Product
 Table 74. QIAGEN Revenue in EGFR Mutation Test Business (2020-2025) & (US$ Million)
 Table 75. QIAGEN Recent Development
 Table 76. Agilent Technologies Company Details
 Table 77. Agilent Technologies Business Overview
 Table 78. Agilent Technologies EGFR Mutation Test Product
 Table 79. Agilent Technologies Revenue in EGFR Mutation Test Business (2020-2025) & (US$ Million)
 Table 80. Agilent Technologies Recent Development
 Table 81. Hologic Company Details
 Table 82. Hologic Business Overview
 Table 83. Hologic EGFR Mutation Test Product
 Table 84. Hologic Revenue in EGFR Mutation Test Business (2020-2025) & (US$ Million)
 Table 85. Hologic Recent Development
 Table 86. Novartis Company Details
 Table 87. Novartis Business Overview
 Table 88. Novartis EGFR Mutation Test Product
 Table 89. Novartis Revenue in EGFR Mutation Test Business (2020-2025) & (US$ Million)
 Table 90. Novartis Recent Development
 Table 91. Roche Company Details
 Table 92. Roche Business Overview
 Table 93. Roche EGFR Mutation Test Product
 Table 94. Roche Revenue in EGFR Mutation Test Business (2020-2025) & (US$ Million)
 Table 95. Roche Recent Development
 Table 96. Genomic Health Company Details
 Table 97. Genomic Health Business Overview
 Table 98. Genomic Health EGFR Mutation Test Product
 Table 99. Genomic Health Revenue in EGFR Mutation Test Business (2020-2025) & (US$ Million)
 Table 100. Genomic Health Recent Development
 Table 101. Research Programs/Design for This Report
 Table 102. Key Data Information from Secondary Sources
 Table 103. Key Data Information from Primary Sources
 Table 104. Authors List of This Report


List of Figures
 Figure 1. EGFR Mutation Test Picture
 Figure 2. Global EGFR Mutation Test Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global EGFR Mutation Test Market Share by Type: 2024 VS 2031
 Figure 4. DNA Sequencing Features
 Figure 5. Kits Features
 Figure 6. Global EGFR Mutation Test Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global EGFR Mutation Test Market Share by Application: 2024 VS 2031
 Figure 8. Cancer Hospitals Case Studies
 Figure 9. Clinical Research Institutes Case Studies
 Figure 10. EGFR Mutation Test Report Years Considered
 Figure 11. Global EGFR Mutation Test Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global EGFR Mutation Test Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global EGFR Mutation Test Market Share by Region: 2024 VS 2031
 Figure 14. Global EGFR Mutation Test Market Share by Players in 2024
 Figure 15. Global Top EGFR Mutation Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in EGFR Mutation Test as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by EGFR Mutation Test Revenue in 2024
 Figure 17. North America EGFR Mutation Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America EGFR Mutation Test Market Share by Country (2020-2031)
 Figure 19. United States EGFR Mutation Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada EGFR Mutation Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe EGFR Mutation Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe EGFR Mutation Test Market Share by Country (2020-2031)
 Figure 23. Germany EGFR Mutation Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France EGFR Mutation Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. EGFR Mutation Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy EGFR Mutation Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia EGFR Mutation Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries EGFR Mutation Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific EGFR Mutation Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific EGFR Mutation Test Market Share by Region (2020-2031)
 Figure 31. China EGFR Mutation Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan EGFR Mutation Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea EGFR Mutation Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia EGFR Mutation Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India EGFR Mutation Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia EGFR Mutation Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America EGFR Mutation Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America EGFR Mutation Test Market Share by Country (2020-2031)
 Figure 39. Mexico EGFR Mutation Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil EGFR Mutation Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa EGFR Mutation Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa EGFR Mutation Test Market Share by Country (2020-2031)
 Figure 43. Turkey EGFR Mutation Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia EGFR Mutation Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE EGFR Mutation Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Abbott Revenue Growth Rate in EGFR Mutation Test Business (2020-2025)
 Figure 47. Merck Revenue Growth Rate in EGFR Mutation Test Business (2020-2025)
 Figure 48. Thermo Fisher Scientific Revenue Growth Rate in EGFR Mutation Test Business (2020-2025)
 Figure 49. Illumina Revenue Growth Rate in EGFR Mutation Test Business (2020-2025)
 Figure 50. BioMerieux Revenue Growth Rate in EGFR Mutation Test Business (2020-2025)
 Figure 51. QIAGEN Revenue Growth Rate in EGFR Mutation Test Business (2020-2025)
 Figure 52. Agilent Technologies Revenue Growth Rate in EGFR Mutation Test Business (2020-2025)
 Figure 53. Hologic Revenue Growth Rate in EGFR Mutation Test Business (2020-2025)
 Figure 54. Novartis Revenue Growth Rate in EGFR Mutation Test Business (2020-2025)
 Figure 55. Roche Revenue Growth Rate in EGFR Mutation Test Business (2020-2025)
 Figure 56. Genomic Health Revenue Growth Rate in EGFR Mutation Test Business (2020-2025)
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Human EGFR Gene Mutation Detection Kit Market Research Report 2024
Global Epidermal Growth Factor Receptor Inhibitors Market Research Report 2024
Global EGFR TKI Market Research Report 2024
Global EGFR Mutation Test Kit Market Research Report 2025
Global Human EGFR KRAS BRAF PIK3CA ALK ROS1 Gene Mutation Detection Kit Market Research Report 2024
Global Epidermal Growth Factor Receptor EGFR Inhibitor Market Insights Forecast to 2030
Global EGFR TKI for Advanced NSCLC Market Research Report 2024
Global Epidermal Growth Factor Receptor EGFR ELISA Kit Market Research Report 2024
Global HER2 Tumor Marker Testing Market Research Report 2024
Erlotinib Hydrochloride Tablet Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dacomitinib API Market Research Report 2024
Global Cosmetic Grade EGF Market Research Report 2025
Global Pan cancer Genetic Testing Market Research Report 2025
Global Human Gene Mutation Test Kit Market Research Report 2024
Global Saracatinib Market Research Report 2024
Global Cetuximab Market Insights Forecast to 2030
Global Afatinib API Market Research Report 2024
Global Epidermal Growth Factor EGF Antibody Market Research Report 2024
Global Icotinib API Market Research Report 2024
Global Epidermal Growth Factor Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions